Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$2.6MFederal grants as PI4 awards
6Patents grantedLatest Mar 17, 2026
44Papers1,348 citations
Federal awards and patents by year
AwardsPatents
4 awards · $2.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 10, 2019 | NIH | SBIR Phase I Overcoming BTK inhibitor resistance in B-cell malignancies | $300K | SignalRx Pharmaceuticals Inc. |
| Aug 20, 2018 | NIH | STTR Phase I Discovery of novel CDK4/6-PI3K-BRD4 inhibitor SRX3177 for augmented anti-cancer activity | $300K | SignalRx Pharmaceuticals Inc. |
| Jun 11, 2018 | NIH | STTR Phase II Development of the first-in-class novel dual PI-3K/BRD4 inhibitor SF2523 | $648K | SignalRx Pharmaceuticals Inc. |
| Jul 11, 2017 | NIH | STTR Phase II Development of the first-in-class novel dual PI-3K/BRD4 inhibitor SF2523 | $1.3M | SignalRx Pharmaceuticals Inc. |
7 patents as inventor
- US 10174032SignalRx Pharmaceuticals Inc.Jan 8, 2019
- US 11472814SignalRx Pharmaceuticals Inc.Oct 18, 2022
- US 11760762SignalRx Pharmaceuticals Inc.Sep 19, 2023
- US 12570668SignalRx Pharmaceuticals Inc.Mar 10, 2026
- US 12577254SignalRx Pharmaceuticals Inc.Mar 17, 2026
- US 9981983SignalRx Pharmaceuticals Inc.May 29, 2018
- US SignalRx Pharmaceuticals Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#739
Awards as PI#566
Patents#15
Companies
- SignalRx Pharmaceuticals Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.